文献速递传染病防控与疫情报告免疫规划

伊朗奥密克戎感染成人既往感染与疫苗接种史与临床结局的回顾性登记研究

Clinical outcomes among SARS-CoV-2 omicron-infected adults according to prior infection and vaccination history in Iran: A retrospective registry-based study.
PubMed 文献 · Vaccine · 2026-06-20

该研究基于伊朗哈马丹省2022年3月至2023年3月4674例实验室确诊奥密克戎感染成人,按既往免疫状态分四组,比较住院和死亡结局。混合免疫组住院和死亡比例低于仅疫苗组,仅感染组也优于仅疫苗组;调整年龄和临床协变量后关联减弱但方向一致。分析以感染者为条件,结果应解读为病例结局差异而非感染防护。

要点

  • 混合免疫者住院和死亡比例低于仅接种疫苗者。
  • 仅既往感染者的结局也优于仅接种疫苗者。
  • 调整年龄和临床协变量后关联减弱但方向一致。

核心结论

  • 在实验室确诊奥密克戎感染的成人中,既往混合免疫与较仅接种疫苗更有利的临床结局相关。
  • 因分析以感染为条件,发现应解读为病例结局差异而非对感染的防护。

研究设计与样本

  • 回顾性登记研究,纳入伊朗哈马丹省2022年3月至2023年3月4674例实验室确诊COVID-19成人。
  • 按既往免疫状态分四组:无 documented 免疫(V-Inf-)、仅疫苗(V+Inf-)、仅感染(V-Inf+)、混合免疫(V+Inf+)。
  • 主要结局为感染者的住院和死亡,采用多变量logistic回归调整年龄、性别、合并症和奥密克戎亚变异流行日历期。

主要发现

  • 混合免疫(V+Inf+)的观察住院和死亡比例低于仅疫苗(V+Inf-)。
  • 仅疫苗(V+Inf-)的观察住院和死亡比例最高。
  • 仅感染(V-Inf+)的结局也优于仅疫苗(V+Inf-)。
  • 调整年龄和临床协变量后关联减弱但方向一致。

临床怎么用

  • 对奥密克戎感染成人,评估既往感染和疫苗接种史有助于识别住院和死亡风险较高者。
  • 仅接种疫苗者可能仍属高风险人群,需加强临床监测。
  • 结果不支持将混合免疫视为感染防护,防控措施应继续针对感染 acquisition。

局限性

  • 回顾性登记设计可能存在残余混杂。
  • 分析以感染为条件,不能推断对感染的保护效果。
  • 单省数据和中东人群异质性疫苗平台可能限制外推。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Omicron subvariants of SARS-CoV-2 have challenged immunity derived from prior infection and vaccination. Evidence from Middle Eastern populations using heterogeneous vaccine platforms remains limited. We evaluated associations between pre-existing immunity profiles and clinical outcomes among laboratory-confirmed Omicron-infected adults in Iran. METHODS: We conducted a retrospective registry-based study in Hamedan Province, Iran, including 4674 adults with laboratory-confirmed COVID-19 between March 2022 and March 2023. Participants were classified into four pre-existing immunity groups: no documented immunity (V - Inf-), vaccination only (V + Inf-), prior infection only (V - Inf+), and hybrid immunity (V + Inf+). The primary outcomes were hospitalization and mortality among infected individuals. Multivariable logistic regression models adjusted for age, sex, comorbidities, and calendar period corresponding to predominant Omicron subvariant circulation. RESULTS: Among infected individuals, hybrid immunity (V + Inf+) was associated with lower observed hospitalization and mortality than vaccination only (V + Inf-). Vaccination only was associated with the highest observed hospitalization and mortality proportions. Prior infection only (V - Inf+) was also associated with more favorable outcomes than vaccination only. Associations were attenuated after adjustment for age and clinical covariates but remained directionally consistent. CONCLUSIONS: Among adults with laboratory-confirmed Omicron infection, pre-existing hybrid immunity was associated with more favorable clinical outcomes than vaccination only. Because analyses were conditioned on infection, the findings should be interpreted as differences in outcomes among cases rather than protection against acquiring infection.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Torkaman-Asadi F, Bakhtiari S, Safarzadeh M, et al. Clinical outcomes among SARS-CoV-2 omicron-infected adults according to prior infection and vaccination history in Iran: A retrospective registry-based study. Vaccine. 2026. PMID: 42322678. doi:10.1016/j.vaccine.2026.128868

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。